C. elegans has the ability to synthesize long chain poly unsaturated fatty acids (LC PUFAs) up to arachidonic acid (20:4n6) and eicosapentaenoic acid (EPA, 20:5n3) de novo , but not docosahexaenoic acid (DHA, 22:6n3). The
fat-3 mutant of C. elegans , however, is lacking a functional delta-6 fatty acid desaturase enzyme, and is, therefore, unable to synthesize LC PUFAs, which makes it an attractive model for studying these molecules in vivo . This mutant shows pleiotropic effects such as dumpy body shape, decreased brood size, slowed development, and decreases in the function of three of the four muscle groups. It has previously been shown that the mutant worms can be rescued by growth on media including fatty acids that already contain the delta-6 unsaturation such as 18:3n6, 20:3n6, 20:4n6, and 20:5n3. We have been able to show that, in addition to the fatty acids mentioned above, DHA, has the same ability to rescue the phenotype of the
fat-3 mutant as scored by body bends/minute (a measure of body wall muscle activity) and increased biomass. Interestingly, a dietary w-3 supplement (fish oil pills) also restores the
fat-3 mutant to wild type body wall muscle activity. Lipid analysis was performed on both WT worms and
fat-3 worms cultured with and without exogenously fed DHA or EPA to investigate the accumulation of these molecules in specific lipid classes.